MedTrace Logo

Involvement of Nervous System in Muscle Weakness in COPD Patients

NCT01679782 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 137

Last updated 2015-03-10

No results posted yet for this study

Summary

The purpose of this study is to determine whether nervous system alterations and motor drive failure can contribute to muscle weakness in COPD during voluntary movement. If necessary, we will look after the role of nocturnal hypoxia in these alterations.

Conditions

Sponsors & Collaborators

  • M2H laboratory, Montpellier University

    collaborator OTHER

  • ANRT, National French Agency for Technological Researches

    collaborator UNKNOWN

  • 5 Santé

    lead OTHER

Principal Investigators

  • Alain AV Varray, Pr · M2H laboratory, Montpellier

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01679782 on ClinicalTrials.gov